Heart Disease Trial, Recruiting (NCT06377449)

Heart Disease Trial, Recruiting NCT06377449 Sponsor: Saint Petersburg State University, Russia Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06377449 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who had open heart surgery using a heart-lung bypass machine (a machine that temporarily takes over the work of the heart and lungs) between 15 December 2023 and 15 December 2024
People who have signed a consent form agreeing to take part in the study

Who may not be able to join:

People who have had a repeat open heart surgery using the heart-lung bypass machine (i.e., not their first such operation)
People who have a history of surgery on the lungs or lung cancer
People with a severe (Stage III) form of chronic obstructive pulmonary disease (a long-term lung condition that makes breathing difficult)
People with advanced chronic kidney disease (Stage 4 or 5), meaning the kidneys are functioning at a significantly reduced level
People considered to be low-risk patients according to a scoring system used by the Society of Thoracic Surgeons (a tool doctors use to estimate the risk of complications from heart surgery) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +79819553639

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06377449

Sponsor: Saint Petersburg State University, Russia

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: +79819553639

More information: https://clinicaltrials.gov/study/NCT06377449

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who had open heart surgery using a heart-lung bypass machine (a machine that temporarily takes over the work of the heart and lungs) between 15 December 2023 and 15 December 2024
People who have signed a consent form agreeing to take part in the study

Who may not be able to join:

People who have had a repeat open heart surgery using the heart-lung bypass machine (i.e., not their first such operation)
People who have a history of surgery on the lungs or lung cancer
People with a severe (Stage III) form of chronic obstructive pulmonary disease (a long-term lung condition that makes breathing difficult)
People with advanced chronic kidney disease (Stage 4 or 5), meaning the kidneys are functioning at a significantly reduced level
People considered to be low-risk patients according to a scoring system used by the Society of Thoracic Surgeons (a tool doctors use to estimate the risk of complications from heart surgery) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Saint Petersburg State University, Russia

Registry

ClinicalTrials.gov

Start date

15 May 2024

Est. completion

15 May 2025

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

The number of participants with interstitial pulmonary edema at the day of hospital discharge, according to ultrasound lung examination

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov